HeartSciences Has Been Granted Indian Patent Application 201817014481 By The Indian Patent Office
HeartSciences Has Been Granted Indian Patent Application 201817014481 By The Indian Patent Office
Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW))))) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has been granted Indian Patent Application 201817014481 by the Indian Patent Office (IPO).
心臟測試實驗室有限公司 d/b/a HeartSciences（納斯達克股票代碼：HSCS，HSCSW）））（“HeartSciences” 或 “公司”），一家由人工智能（AI）驅動的醫療技術公司，致力於改造心電圖/心電圖以通過儘早發現心臟病來挽救生命，今天宣佈，印度專利局（IPO）已批准印度專利申請201817014481。
To date, HeartSciences has been granted nine US patents and 35 international patents for a total of 44 granted patents. Issued international patents are across key countries including China, Brazil, Canada, India, South Korea, Mexico, and key European markets such as Germany, France, UK, Italy and the Netherlands.
迄今爲止，HeartSciences已獲得九項美國專利和35項國際專利，共授予44項專利。已頒發的國際專利遍及主要國家，包括中國、巴西、加拿大、印度、韓國、墨西哥以及德國、法國、英國、意大利和荷蘭等主要歐洲市場。
譯文內容由第三人軟體翻譯。